Podowart: Clinically Proven Topical Treatment for Warts
| Product dosage: 10 ml | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 3 | $22.11 | $66.33 (0%) | 🛒 Add to cart |
| 6 | $20.10 | $132.67 $120.61 (9%) | 🛒 Add to cart |
| 9 | $19.54 | $199.00 $175.89 (12%) | 🛒 Add to cart |
| 10 | $19.10
Best per bottle | $221.12 $190.96 (14%) | 🛒 Add to cart |
Synonyms | |||
Podowart is a physician-formulated topical solution designed for the targeted treatment of common warts, plantar warts, and other benign epithelial growths caused by the human papillomavirus (HPV). Its active ingredient, podophyllotoxin, is derived from natural sources and works by inhibiting viral replication and inducing localized necrotic action on affected tissue. This prescription-strength treatment offers a precise, non-invasive alternative to surgical procedures, allowing for controlled application and reduced risk of scarring. Clinically validated for efficacy and safety, Podowart is a first-line option in dermatological practice for patients seeking reliable, at-home management of cutaneous warts.
Features
- Contains 0.5% podophyllotoxin as the active ingredient
- Alcohol-based solution for rapid drying and precise application
- Single-use applicators for hygienic and controlled dosage
- Prescription-strength formulation
- Stable shelf life of 24 months unopened
- Packaged in light-resistant amber bottles to maintain potency
Benefits
- Effectively destroys wart tissue through antimitotic and antiviral actions
- Reduces recurrence rates by targeting HPV-infected cells
- Minimizes risk of scarring compared to cryotherapy or excision
- Allows for self-application under medical guidance
- Short treatment duration with visible results within weeks
- Cost-effective compared to repeated clinical procedures
Common use
Podowart is indicated for the topical treatment of external genital warts (condylomata acuminata), as well as common warts (verruca vulgaris) and plantar warts. It is most effective on moist, non-keratinized surfaces but can be used on thicker lesions following appropriate preparation. The solution is applied directly to the wart tissue, avoiding surrounding healthy skin. Treatment is typically administered in cycles, with periods of application followed by rest intervals to monitor response and allow for healing. It is not suitable for mucosal surfaces or internal use.
Dosage and direction
Apply Podowart solution twice daily (morning and evening) for 3 consecutive days, followed by a 4-day treatment-free interval. This one-week cycle may be repeated for up to 4 weeks, depending on clinical response. Use the supplied applicator to dab the solution onto each wart, ensuring complete coverage without oversaturation. Allow the treated area to dry thoroughly before contact with clothing or skin. Wash hands immediately after application. Do not exceed recommended frequency or duration of use.
Precautions
- For external use only. Avoid contact with eyes, mucous membranes, and broken skin.
- Do not apply to large areas or numerous warts simultaneously due to systemic absorption risk.
- Use with caution in diabetic patients or those with circulatory disorders.
- Pregnancy and breastfeeding: Contraindicated due to potential teratogenic effects.
- Keep away from open flames—solution is flammable until dry.
- Discontinue use if excessive irritation, swelling, or pain occurs.
Contraindications
Podowart is contraindicated in patients with known hypersensitivity to podophyllotoxin or any component of the formulation. It should not be used during pregnancy or by women attempting to conceive. Avoid use on bleeding warts, birthmarks, moles, or unusual lesions not diagnosed as warts. Do not administer to children under 12 years of age unless under specialist supervision. Contraindicated in patients with poorly controlled diabetes or compromised immune function.
Possible side effects
Common local reactions include burning, itching, erythema, and tenderness at the application site. Mild erosion or superficial ulceration may occur as part of the therapeutic effect. Less frequently, patients may experience inflammation, pain, or skin peeling. Systemic absorption is rare with proper use but may lead to nausea, vomiting, or neurological symptoms if applied excessively. Allergic contact dermatitis is possible in sensitized individuals.
Drug interaction
No clinically significant drug interactions have been documented with topical podophyllotoxin. However, concomitant use with other topical agents (e.g., salicylic acid, imiquimod) on the same area may increase irritation and is not recommended. Use caution with immunosuppressive therapies, as impaired healing may occur. Theoretical interactions exist with drugs affecting cytochrome P450 metabolism, though systemic levels are typically negligible.
Missed dose
If a dose is missed, apply as soon as remembered unless it is nearly time for the next scheduled application. Do not double the dose to make up for a missed application. Resume the regular dosing schedule. Consistency supports optimal outcomes, but minor deviations are unlikely to significantly affect treatment efficacy.
Overdose
Overapplication may cause severe local reactions including ulceration, bleeding, or intense pain. Systemic toxicity—though rare—may present with nausea, vomiting, diarrhea, CNS disturbances, or bone marrow suppression. In case of accidental ingestion or widespread application, seek immediate medical attention. Treatment is supportive; remove any residual solution and manage symptoms appropriately.
Storage
Store at room temperature (15–30°C) in the original container. Keep tightly closed and protect from light. Do not freeze. Keep out of reach of children and pets. Discard any unused solution 3 months after first opening. Do not transfer to unlabeled containers.
Disclaimer
This product is for prescription use only. The information provided does not replace professional medical advice. Diagnosis and treatment should be undertaken by a qualified healthcare provider. Individual results may vary. Use strictly as directed by a physician.
Reviews
Clinical studies demonstrate complete clearance rates of 70–80% after 4 weeks of treatment, with low recurrence rates. Patients report high satisfaction due to convenience and minimal scarring. Dermatologists value its precision and reduced need for invasive procedures. Some users note mild to moderate discomfort during application, though this is generally well-tolerated.